Japan· JP-3999466A1026
スペソリマブ（遺伝子組換え）
A medicinal product containing スペソリマブ（遺伝子組換え）, registered in Japan by 日本ベーリンガーインゲルハイム, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- スペソリマブ（遺伝子組換え）
- Manufacturer
- 日本ベーリンガーインゲルハイム
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
スペソリマブ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSPEVIGOBoehringer Ingelheim Pharmaceuticals, Inc.
- BelgiumSpevigo 150 mgLeo Pharma
- IcelandSpevigoLEO Pharma A/S*
- NetherlandsSpevigo 150 mg, oplossing voor injectie in voorgevulde spuitLeo Pharma A/S
- PolandSpevigoBoehringer Ingelheim International GmbH
- SwedenSpevigo 150 mg Injektionsvätska, lösning i förfylld sprutaLEO Pharma A/S
- CzechiaSPEVIGOLEO Pharma A/S, Ballerup
- SpainSPEVIGO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADALeo Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Spevigo
- Liechtenstein · Spevigo
- Norway · Spevigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17a11af3-70fe-4d1f-a836-b8cd8c5f3551 GET /v1/drugs/17a11af3-70fe-4d1f-a836-b8cd8c5f3551?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "４５０ｍｇ７．５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999466A1026",
"category": "注射薬",
"price_yen": 963821,
"generic_name": "スペソリマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about スペソリマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.